Načítá se...
GENERIC DRUGS IN THE UNITED STATES: POLICIES TO ADDRESS PRICING AND COMPETITION
The cost of prescription drugs in the U.S. continues to be a source of concern for patients, caregivers, and policymakers. Drug prices typically decline rapidly once generic drugs receive U.S. Food and Drug Administration (FDA) approval and enter the market, but the past decade has witnessed rising...
Uloženo v:
| Vydáno v: | Clin Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355356/ https://ncbi.nlm.nih.gov/pubmed/30471089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1314 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|